Digital 3D Breast Tomosynthesis Versus 2D in Clinical Evaluation of High Risk Women
Conditions
Breast Cancer
Conditions: Keywords
digital breast tomosynthesis
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Cohort, Time Perspective: Prospective
Overall Status
Recruiting
Summary
Patients with a higher breast cancer risk (higher than 17% according to the IBIS calculation) will receive a 2D digital mammography together with a 3D tomosynthesis (so called combo tomo) of both breasts in two views in order to investigate the additional value of tomosynthesis in the diagnosis of breast cancer.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: 90 Years
Minimum Age: 40 Years
Gender: Female
Criteria: Inclusion Criteria:

- women

- more than 17% risk for breast cancer (IBIS calculation)

- > 40y old

Exclusion Criteria:

- < 40y old
Location
UZLeuven
Leuven, Belgium
Status: Recruiting
Contact: Chantal Van Ongeval - +3216343780 - chantal.vanongeval@uzleuven.be
Start Date
August 2014
Completion Date
August 2017
Sponsors
Universitaire Ziekenhuizen Leuven
Source
Universitaire Ziekenhuizen Leuven
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page